About this trial
This study aims to investigate the pathogenesis of Peripheral Artery Disease (PAD) and Carotid Artery Stenosis (CAS) using a comprehensive multi-omics and multi-modal imaging approach. The study will enroll patients diagnosed with PAD or CAS and perform advanced imaging techniques, including NIR-II Imaging, DUS-based V-flow Imaging, and Laser Speckle Imaging, to assess vascular structure and function. Simultaneously, single-cell transcriptomics, metabolomics, lipidomics, and proteomics analyses will be conducted on patient samples to identify key molecular targets and pathways involved in disease progression. Machine learning algorithms will be employed to integrate imaging and multi-omics data, enabling the development of predictive models for more accurate disease diagnosis and stratification. The findings from this study are expected to provide novel insights into the molecular mechanisms underlying PAD and CAS and contribute to the development of personalized therapeutic strategies.
Eligibility criteria
Qualifiers
The study subjects are inpatients from the Department of Vascular Surgery at the Second Hospital of Shanxi Medical University.
Males or females aged between 18 and 85 years.
Diagnosed with Peripheral Artery Disease (PAD) or Carotid Artery Stenosis (CAS).
Participants are conscious, fully informed about the study content, and have signed the informed consent form, agreeing to participate in this study.
Disqualifiers
Non-atherosclerotic stenosis (e.g., vasculitis or dissection).
PAD patients who have previously undergone interventional treatments (e.g., balloon angioplasty or stent placement) and/or surgical procedures.
Patients with heart failure classified as NYHA Class II-IV or those with a history of coronary artery disease.
Patients with acute infections, tumors, severe arrhythmias, psychiatric disorders, or drug/alcohol addiction.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Yijie Ning
Lead sponsor
Second Hospital of Shanxi Medical University
Sponsor institution